Yang C, Yang H, Kim H, Chung N, Shin J, Min H
Biomater Res. 2024; 28:0054.
PMID: 39135549
PMC: 11310713.
DOI: 10.34133/bmr.0054.
Raghuram N, Temel E, Kawamata T, Kozma K, Loch A, Wang W
Breast Cancer Res. 2024; 26(1):86.
PMID: 38807216
PMC: 11134842.
DOI: 10.1186/s13058-024-01842-5.
Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong J, Ladha F
Br J Cancer. 2024; 131(1):171-183.
PMID: 38760444
PMC: 11231151.
DOI: 10.1038/s41416-024-02697-5.
Lyu C, Bhimani A, Draus W, Weigel R, Chen S
Mol Cell Biol. 2023; 43(12):650-663.
PMID: 38099640
PMC: 10761066.
DOI: 10.1080/10985549.2023.2285833.
Zhu S, Wu Y, Song B, Yi M, Yan Y, Mei Q
J Hematol Oncol. 2023; 16(1):100.
PMID: 37641116
PMC: 10464091.
DOI: 10.1186/s13045-023-01497-3.
Virginal Breast Hypertrophy: A Case Report.
Soliman S, Algatheradi M, Aljahwashi T, Alhussan T, Alqahtani R, Ali N
Cureus. 2023; 15(6):e40067.
PMID: 37425593
PMC: 10326455.
DOI: 10.7759/cureus.40067.
The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study.
E Y, Yu Q, Sun T, Xue H, Zhao X, Zheng H
BMC Cancer. 2023; 23(1):520.
PMID: 37291517
PMC: 10249301.
DOI: 10.1186/s12885-023-11020-z.
NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer.
Purazo M, Ice R, Shimpi R, Hoenerhoff M, Pugacheva E
Cancers (Basel). 2023; 15(4).
PMID: 36831460
PMC: 9954084.
DOI: 10.3390/cancers15041119.
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
Mazumdar A, Tahaney W, Hill J, Zhang Y, Ramachandran S, Kawedia J
Cancer Prev Res (Phila). 2022; 15(12):791-802.
PMID: 35981902
PMC: 9762336.
DOI: 10.1158/1940-6207.CAPR-22-0106.
Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential.
Vallone S, Garcia Sola M, Schere-Levy C, Meiss R, Hermida G, Chodosh L
Dis Model Mech. 2022; 15(3).
PMID: 35044452
PMC: 8990024.
DOI: 10.1242/dmm.049286.
Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway.
Martinez J, Mo Q, Xu Y, Qin L, Li Y, Xu J
Int J Biol Sci. 2022; 18(1):229-241.
PMID: 34975329
PMC: 8692138.
DOI: 10.7150/ijbs.65763.
Dual recombinase action in the normal and neoplastic mammary gland epithelium.
Radler P, Vistisen K, Triplett A, Dennaoui R, Li Y, Shrestha H
Sci Rep. 2021; 11(1):20775.
PMID: 34675248
PMC: 8531329.
DOI: 10.1038/s41598-021-00231-8.
Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
Lyu C, Ye Y, Lensing M, Wagner K, Weigel R, Chen S
JCI Insight. 2021; 6(18).
PMID: 34343132
PMC: 8492335.
DOI: 10.1172/jci.insight.150532.
Transgenic mouse models of breast cancer.
Regua A, Arrigo A, Doheny D, Wong G, Lo H
Cancer Lett. 2021; 516:73-83.
PMID: 34090924
PMC: 8260455.
DOI: 10.1016/j.canlet.2021.05.027.
Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing.
Liu C, Wu P, Zhang A, Mao X
Front Oncol. 2021; 11:593337.
PMID: 33842308
PMC: 8032937.
DOI: 10.3389/fonc.2021.593337.
Virginal breast hypertrophy in a 14-year-old girl: A case report.
Pokhrel B, Gautam S, Sharma S, Pokhrel N, Bhatta N, Rayamajhi S
Clin Case Rep. 2021; 9(1):198-202.
PMID: 33489159
PMC: 7813066.
DOI: 10.1002/ccr3.3498.
PTEN and Other PtdIns(3,4,5)P Lipid Phosphatases in Breast Cancer.
Csolle M, Ooms L, Papa A, Mitchell C
Int J Mol Sci. 2020; 21(23).
PMID: 33276499
PMC: 7730566.
DOI: 10.3390/ijms21239189.
PtdIns(3,4,5)P-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis.
Srijakotre N, Liu H, Nobis M, Man J, Yip H, Papa A
Proc Natl Acad Sci U S A. 2020; 117(45):28056-28067.
PMID: 33097662
PMC: 7668035.
DOI: 10.1073/pnas.2006445117.
MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
Zhang Y, Chen D, Zhang G, Wu X, Zhou L, Lin Y
Oncol Lett. 2020; 20(5):160.
PMID: 32934728
PMC: 7471709.
DOI: 10.3892/ol.2020.12021.
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges.
Lee J, Yost S, Yuan Y
Cancers (Basel). 2020; 12(6).
PMID: 32486021
PMC: 7352772.
DOI: 10.3390/cancers12061404.